Clinical Trial Search

Primary: Mean Change From Baseline in the Convenience Subscale Score (CSS) Derived From the Treatment Satisfaction Questionnaire for Medication (TSQM v 1.4) Using Items 9 (Ease…

Primary: Number of Participants With Mean Sitting Cuff Blood Pressure <140/90 mmHg at the End of 6 Weeks of Treatment — 139; 137; 64; 64 Participants — p=0.8822

Primary: Percent Change From Baseline in Low-Density Lipoprotein-Cholesterol (LDL-C) — -20.1; -58.5 Percent change — p=<0.001

Primary: Number of Subjects Reporting Fever Above 39.0 Degree Celsius (°C) — 11; 8 subjects

Primary: Percentage of Change From Baseline in WOMAC Pain Subscale Score at Week 12 — 58.3; 58.7 percentage of change

Primary: Patient Global Rating of Pain for the Study Period (12 Weeks) — 19; 16; 26; 29 participants

Primary: Percent Change From Baseline in Low Density Lipoprotein Cholesterol at Week 12 — -10.0; -5.5 Percent — p=0.006

Primary: Baseline Positive and Negative Symptoms of Schizophrenia (PANSS) Total Score — 91.6; 95.9; 92.7 points on a scale

Primary: Partial Onset Seizure (POS) Frequency Per Week - Intention-To-Treat (ITT) Population — 0.912; 1.067 seizures per week (log-transformed data) — p=0.038

Primary: Change in Panic Disorder Symptoms, Phase 1 (Week 0 - Week 6) — 4.3 Points on a scale — p=0.0000

Primary: Number of Seropositive Subjects for Anti-hepatitis A Virus (HAV) Antibodies Following the Second Dose of Havrix — 88; 84; 77 Participants

Primary: Concentration of Anti-Protein D Antibodies — 2277.6 EL.U/mL

Primary: Mean Change of Sitting dBP From Baseline to Week 12 — -14.80; -11.60 mmHg

Primary: Mean Change (Week 8 - Baseline) in the Autistic Behavior Checklist (ABC) Irritability Subscale Score — -8.4; -12.4; -13.2; -14.4 units on a scale

Primary: Percentage of Subjects Reporting Adverse Events During Combination Therapy, Either in the Preceding Double-blind Studies or in This Open-label Study — 83; 86; 85…